相关实验视频
Updated: Jul 12, 2026

07:45
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
Published on: November 6, 2018
儿童烧伤特征与年龄相关的差异:卡贝尔·亨廷顿医院的回顾性分析
Armein Rahimpour1, Isabella G Stuart1, Nathan Fox1
1General Surgery, Marshall University Joan C. Edwards School of Medicine, Huntington, USA.
Cureus
|April 4, 2025
概括
在阿巴拉契亚州的儿童烧伤伤在烧伤来源和严重程度上显示了与年龄相关的差异. 较小的孩子会经历烧伤,而青少年则面临更严重的火焰烧伤,需要量身定制的预防策略.
科学领域:
- 儿科烧伤研究的研究.
- 在阿巴拉契亚州的伤害预防.
- 年龄特定的健康结果.
背景情况:
- 儿童燃烧伤害是导致发病和死亡的重要原因,特别是在阿巴拉契亚.
- 在阿巴拉契亚地区的地理隔离给专门的儿科烧伤护理带来了挑战.
- 在阿巴拉契亚地区,儿童烧伤的年龄特异性研究有限.
研究的目的:
- 确定影响阿巴拉契亚儿科人口中不同年龄组的因素.
- 为了确定哪个儿科年龄组有更高的严重烧伤风险.
- 了解阿巴拉契亚地区儿科烧伤的年龄相关模式.
主要方法:
- 在2010年1月至2023年6月期间入院的218名儿科患者 (0-18岁) 的回顾性研究.
- 患者分为四个年龄组:0-5,6-10,11-15和16-18岁.
- 分析燃烧源,停留时间 (LOS),总体表面积 (TBSA) 和体重指数 (BMI) 使用千平方测试和ANOVA.
主要成果:
- 小孩 (0-10岁) 烧伤最常见,而青少年 (11-18岁) 烧伤最常见.
- 青少年 (16-18岁) 与年轻人相比,经历了更长的停留时间 (LOS) 和更高的总体表面积 (TBSA).
- 在LOS,TBSA和BMI (p<0.05) 中观察到与年龄相关的显著变化.
结论:
- 燃烧源,LOS,TBSA和BMI的明显与年龄相关的模式需要特定年龄的预防计划.
- 青少年面临着更严重的烧伤严重程度,火焰烧伤和增加的TBSA表明,需要有针对性的干预措施.
- 对长期结果和精确的预防策略的进一步研究对于阿巴拉契亚地区的儿科烧伤护理至关重要.
相关概念视频
Burn Injuries
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

